Encompass Health Corporation (EHC) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
97.74$'dan işlem gören Encompass Health Corporation (EHC), 10B değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 8 Şub 2026Encompass Health Corporation (EHC) Sağlık ve Boru Hattı Genel Bakışı
Encompass Health delivers comprehensive post-acute care through inpatient rehabilitation and home-based services, capitalizing on the growing demand for specialized recovery and hospice care with a strong presence across 42 states and Puerto Rico, offering investors a stable healthcare play.
Yatırım Tezi
Encompass Health presents a notable research candidate within the growing post-acute care market. The company's dual focus on inpatient rehabilitation and home-based services positions it to capitalize on the increasing demand for specialized recovery and hospice care. With a market capitalization of $10.60 billion and a P/E ratio of 18.65, Encompass Health demonstrates financial stability and growth potential. A key value driver is the company's ability to expand its network of hospitals and home health locations, enhancing its market reach and service capabilities. The company's consistent profitability, reflected in a 9.5% profit margin and a 45.4% gross margin, further supports its investment appeal. The dividend yield of 0.68% provides a steady income stream for investors. Upcoming catalysts include continued expansion into underserved markets and potential acquisitions to bolster its service offerings.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market Cap of $10.60B indicates a strong market valuation and investor confidence.
- P/E ratio of 18.65 suggests a reasonable valuation relative to earnings.
- Profit Margin of 9.5% demonstrates efficient operations and profitability.
- Gross Margin of 45.4% reflects a healthy pricing strategy and cost management.
- Dividend Yield of 0.68% provides a steady income stream for investors.
Rakipler & Benzerleri
Güçlü Yönler
- Diversified service offerings in inpatient rehabilitation and home health.
- Extensive geographic footprint across 42 states and Puerto Rico.
- Strong brand reputation and established market presence.
- Experienced management team and skilled workforce.
Zayıflıklar
- Exposure to regulatory changes and reimbursement pressures.
- Dependence on Medicare and Medicaid payments.
- Competition from other post-acute care providers.
- Potential for operational inefficiencies and cost overruns.
Katalizörler
- Upcoming: Continued expansion of home health and hospice services into new geographic markets.
- Ongoing: Strategic acquisitions of smaller regional providers to increase market share.
- Ongoing: Development and implementation of specialized programs for specific patient populations.
- Upcoming: Integration of telehealth and remote monitoring technologies to improve patient outcomes.
- Ongoing: Partnerships with hospitals and healthcare systems to create referral networks.
Riskler
- Potential: Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue.
- Ongoing: Increased competition from other post-acute care providers could erode market share.
- Potential: Economic downturn could reduce patient demand for elective rehabilitation services.
- Ongoing: Regulatory scrutiny and compliance requirements could increase operating costs.
- Potential: Litigation and liability claims could result in significant financial losses.
Büyüme Fırsatları
- Expansion of Home Health and Hospice Services: Encompass Health has a significant opportunity to expand its home health and hospice services, particularly in regions with a growing elderly population. The market for home healthcare is projected to reach $300 billion by 2028, driven by the increasing preference for in-home care among seniors. By increasing its geographic footprint and service offerings in this segment, Encompass Health can capture a larger share of this expanding market, enhancing revenue and profitability. This expansion can be achieved through strategic acquisitions and organic growth initiatives.
- Strategic Acquisitions: Encompass Health can pursue strategic acquisitions to expand its market presence and service capabilities. Acquiring smaller regional providers of inpatient rehabilitation and home health services can provide immediate access to new markets and customer bases. These acquisitions can also bring in specialized expertise and technologies, enhancing the company's competitive advantage. The timeline for these acquisitions would be ongoing, with a focus on identifying and integrating suitable targets over the next 3-5 years.
- Technological Integration: Investing in advanced technologies, such as telehealth and remote monitoring, can improve patient outcomes and reduce costs. Telehealth solutions can enable Encompass Health to provide remote consultations and monitoring, expanding access to care for patients in rural or underserved areas. Remote monitoring devices can track patient vital signs and activity levels, allowing for early detection of potential health issues. The market for telehealth is expected to grow to $50 billion by 2027, presenting a significant opportunity for Encompass Health to enhance its service offerings and improve operational efficiency.
- Partnerships with Healthcare Systems: Collaborating with hospitals and healthcare systems can create referral networks and improve patient access to post-acute care services. By partnering with these organizations, Encompass Health can ensure a steady stream of patients requiring rehabilitation and home healthcare services. These partnerships can also facilitate the integration of care across the continuum, improving patient outcomes and reducing readmission rates. The timeline for establishing these partnerships would be ongoing, with a focus on building relationships with key healthcare providers in each market.
- Focus on Specialized Programs: Developing specialized programs for specific patient populations, such as those recovering from stroke or cardiac events, can attract more patients and enhance the company's reputation. These programs can be tailored to meet the unique needs of each patient group, providing comprehensive and coordinated care. By focusing on these specialized programs, Encompass Health can differentiate itself from competitors and become a preferred provider for patients requiring specialized post-acute care. The timeline for developing and implementing these programs would be 1-2 years, with ongoing evaluation and refinement.
Fırsatlar
- Expansion into underserved markets.
- Strategic acquisitions to increase market share.
- Development of specialized programs for specific patient populations.
- Integration of technology to improve patient outcomes and reduce costs.
Tehditler
- Changes in healthcare regulations and reimbursement policies.
- Increased competition from other post-acute care providers.
- Economic downturn affecting patient demand for services.
- Potential for litigation and liability claims.
Rekabet Avantajları
- Extensive network of hospitals and home health locations.
- Strong reputation for providing high-quality post-acute care.
- Established relationships with referral sources.
- Expertise in managing complex medical conditions.
- Economies of scale in operations.
EHC Hakkında
Encompass Health Corporation, founded in 1983 and headquartered in Birmingham, Alabama, is a prominent provider of post-acute healthcare services in the United States. Originally established as HealthSouth Corporation, the company rebranded to Encompass Health in January 2018, marking a strategic shift to better reflect its comprehensive service offerings. The company operates through two primary segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment offers specialized rehabilitative treatment to patients recovering from conditions such as stroke, neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. These services are provided on both an inpatient and outpatient basis. The Home Health and Hospice segment delivers home health and hospice services, primarily in the Southeast and Texas. Home health services include skilled nursing, medical social work, home health aide services, and physical, occupational, and speech therapy. Hospice services provide in-home care to terminally ill patients and their families. As of June 1, 2022, Encompass Health operated 149 hospitals, 252 home health locations, and 99 hospice locations across 42 states and Puerto Rico, demonstrating a significant geographic footprint and extensive service network.
Ne Yaparlar
- Operates inpatient rehabilitation facilities.
- Provides home health services including skilled nursing and therapy.
- Offers hospice care for terminally ill patients.
- Treats patients recovering from stroke and neurological disorders.
- Provides care for patients with cardiac and pulmonary conditions.
- Offers rehabilitation for brain and spinal cord injuries.
- Provides specialized care for complex orthopedic conditions and amputations.
İş Modeli
- Generates revenue through inpatient rehabilitation services.
- Earns revenue from home health and hospice services.
- Receives payments from Medicare, Medicaid, and private insurance.
- Focuses on providing high-quality, cost-effective post-acute care.
Sektör Bağlamı
Encompass Health operates within the expanding post-acute care industry, driven by an aging population and increasing prevalence of chronic diseases. The market is characterized by a growing demand for rehabilitation and home healthcare services. The competitive landscape includes other major players such as CHE and DVA, as well as regional and local providers. Encompass Health's extensive network of facilities and comprehensive service offerings position it as a leading provider in this fragmented market. The industry is also influenced by regulatory changes and reimbursement policies, which can impact profitability and growth strategies.
Kilit Müşteriler
- Patients recovering from acute illnesses or injuries.
- Individuals requiring rehabilitation services.
- Terminally ill patients and their families.
- Hospitals and healthcare systems seeking post-acute care partners.
Finansallar
Grafik & Bilgi
Encompass Health Corporation (EHC) hisse senedi fiyatı: $97.74 (-1.08, -1.09%)
Son Haberler
-
Encompass Health Expands in Delaware With New 40-Bed Unit Plans
zacks.com · 19 Mar 2026
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
prnewswire.com · 19 Mar 2026
-
Encompass Health Expands Delaware Presence with New Rehabilitation Hospital
MT Newswires · 18 Mar 2026
-
Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware
prnewswire.com · 18 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
EHC için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
Konsensüs hedefi: $153.00
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, EHC'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
Encompass Health Expands in Delaware With New 40-Bed Unit Plans
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
Encompass Health Expands Delaware Presence with New Rehabilitation Hospital
Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware
EHC Hakkında Sıkça Sorulan Sorular
EHC için değerlendirilmesi gereken temel faktörler nelerdir?
Encompass Health Corporation (EHC) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Hisse 17.3x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $153.00 ($97.74'dan +57%). Temel güçlü yan: Diversified service offerings in inpatient rehabilitation and home health.. İzlenmesi gereken birincil risk: Potential: Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue.. Bu bir finansal tavsiye değildir.
EHC MoonshotScore'u nedir?
EHC şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
EHC verileri ne sıklıkla güncellenir?
EHC fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler EHC hakkında ne diyor?
Analistler, EHC için $153.00 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($97.74) yukarı yönlü %57 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.
EHC'a yatırım yapmanın riskleri nelerdir?
EHC için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
EHC'ın P/E oranı nedir?
Encompass Health Corporation (EHC)'nın son P/E oranı 17.3, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.
EHC aşırı değerli mi, yoksa düşük değerli mi?
Encompass Health Corporation (EHC)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 17.3. Analist hedefi $153.00 (mevcut fiyattan +57%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
EHC'ın temettü verimi nedir?
Encompass Health Corporation (EHC) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.